| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VXRT | Vaxart, Inc. | Tucker Sean | SVP, Chief Scientific Officer | Mar 28, 2024 | Option Exercise | $1.30 | 3,902 | 5,073 | 355,695 | Apr 01, 2024, 07:16 PM | |
| VXRT | Vaxart, Inc. | Cummings James F. | Chief Medical Officer | Mar 28, 2024 | Option Exercise | $1.30 | 3,292 | 4,280 | 326,801 | Apr 01, 2024, 07:13 PM | |
| VXRT | Vaxart, Inc. | Tucker Sean | SVP, Chief Scientific Officer | Mar 28, 2023 | Option Exercise | $0.75 | 3,683 | 2,762 | 373,630 | Mar 20, 2024, 08:12 PM | |
| VXRT | Vaxart, Inc. | Tucker Sean | SVP, Chief Scientific Officer | Dec 08, 2023 | Option Exercise | $0.71 | 34,288 | 24,344 | 339,342 | Mar 20, 2024, 08:12 PM | |
| VXRT | Vaxart, Inc. | Tucker Sean | SVP, Chief Scientific Officer | Feb 02, 2024 | Option Exercise | $1.20 | 9,220 | 11,064 | 330,122 | Mar 20, 2024, 08:12 PM | |
| VXRT | Vaxart, Inc. | Lee Phillip E | Chief Financial Officer | Dec 15, 2023 | Option Exercise | $0.63 | 5,943 | 3,744 | 151,808 | Mar 20, 2024, 08:10 PM | |
| VXRT | Vaxart, Inc. | Lee Phillip E | Chief Financial Officer | Dec 08, 2023 | Option Exercise | $0.71 | 35,151 | 24,957 | 157,751 | Mar 20, 2024, 08:10 PM | |
| VXRT | Vaxart, Inc. | Cummings James F. | Chief Medical Officer | Dec 08, 2023 | Option Exercise | $0.71 | 31,409 | 22,300 | 248,058 | Mar 20, 2024, 08:09 PM | |
| VXRT | Vaxart, Inc. | Cummings James F. | Chief Medical Officer | Feb 02, 2024 | Option Exercise | $1.20 | 7,965 | 9,558 | 240,093 | Mar 20, 2024, 08:09 PM | |
| VXRT | Vaxart, Inc. | Berg Edward B | SVP, General Counsel | Dec 08, 2023 | Option Exercise | $0.71 | 33,752 | 23,964 | 189,926 | Mar 20, 2024, 08:07 PM | |
| VXRT | Vaxart, Inc. | Berg Edward B | SVP, General Counsel | Feb 02, 2024 | Option Exercise | $1.20 | 9,220 | 11,064 | 180,706 | Mar 20, 2024, 08:07 PM | |
| VXRT | Vaxart, Inc. | Watson W. Mark | Director | Dec 28, 2022 | Buy | $0.76 | 20,000 | 15,140 | 20,000 | Dec 28, 2022, 05:25 PM | |
| VXRT | Vaxart, Inc. | Yedid Robert A. | Director | Jan 10, 2022 | Sale | $6.01 | 1,500 | 9,015 | 0 | Oct 07, 2022, 05:32 PM | |
| VXRT | Vaxart, Inc. | Yedid Robert A. | Director | Aug 19, 2022 | Option Exercise | $0.94 | 26,240 | 24,774 | 37,355 | Aug 22, 2022, 06:06 PM | |
| VXRT | Vaxart, Inc. | Ahmad Fuad | Interim CFO | Jun 22, 2022 | Buy | $3.22 | 5,000 | 16,100 | 5,000 | Jun 23, 2022, 04:32 PM | |
| VXRT | Vaxart, Inc. | Tucker Sean | SVP, Chief Scientific Officer | Apr 22, 2022 | Option Exercise | $0.77 | 40,000 | 30,800 | 127,631 | Apr 25, 2022, 04:40 PM | |
| VXRT | Vaxart, Inc. | Echerd Margaret | SVP, Principal Accntng Officer | Nov 30, 2021 | Option Exercise | $4.79 | 7,204 | 34,520 | 3,602 | Dec 01, 2021, 04:05 PM | |
| VXRT | Vaxart, Inc. | Echerd Margaret | SVP, Principal Accntng Officer | Sep 10, 2021 | Sale | $5.34 | 3,602 | 19,245 | 1,801 | Sep 13, 2021, 07:29 PM | |
| VXRT | Vaxart, Inc. | Tucker Sean | SVP, Chief Scientific Officer | Aug 10, 2021 | Sale | $10.20 | 4,172 | 42,554 | 43,881 | Aug 11, 2021, 06:53 PM | |
| VXRT | Vaxart, Inc. | Tucker Sean | SVP, Chief Scientific Officer | Aug 10, 2021 | Sale | $10.20 | 5,828 | 59,446 | 51,465 | Aug 11, 2021, 06:53 PM | |
| VXRT | Vaxart, Inc. | Echerd Margaret | SVP, Principal Accntng Officer | Aug 10, 2021 | Option Exercise | $5.79 | 3,602 | 20,862 | 1,801 | Aug 11, 2021, 06:52 PM | |
| VXRT | Vaxart, Inc. | Echerd Margaret | SVP, Principal Accntng Officer | Jul 19, 2021 | Sale | $4.79 | 3,600 | 17,251 | 1,800 | Jul 21, 2021, 04:32 PM | |
| VXRT | Vaxart, Inc. | Yedid Robert A. | Director | Jun 11, 2021 | Sale | $3.25 | 28,240 | 91,763 | 18,240 | Jun 14, 2021, 04:17 PM | |
| VXRT | Vaxart, Inc. | Echerd Margaret | SVP, Principal Accntng Officer | Jun 11, 2021 | Sale | $4.79 | 3,604 | 17,273 | 1,802 | Jun 14, 2021, 04:16 PM | |
| VXRT | Vaxart, Inc. | Echerd Margaret | SVP, Principal Accntng Officer | Jun 09, 2021 | Option Exercise | $4.96 | 95,110 | 471,323 | 47,555 | Jun 11, 2021, 04:17 PM | |
| VXRT | Vaxart, Inc. | Tucker Sean | Chief Scientific Officer | Mar 16, 2021 | Option Exercise | $6.49 | 1,006 | 6,529 | 48,053 | Mar 19, 2021, 05:04 PM | |
| VXRT | Vaxart, Inc. | Latour Wouter | Director | Mar 04, 2021 | Option Exercise | $3.41 | 300,000 | 1,021,950 | 150,000 | Mar 05, 2021, 04:03 PM | |
| VXRT | Vaxart, Inc. | Latour Wouter | Director | Nov 23, 2020 | Sale | $6.32 | 333,334 | 2,108,138 | 0 | Nov 23, 2020, 08:18 PM | |
| VXRT | Vaxart, Inc. | Tucker Sean | Chief Scientific Officer | Aug 13, 2020 | Option Exercise | $6.49 | 4,026 | 26,129 | 51,679 | Aug 14, 2020, 04:21 PM | |
| VXRT | Vaxart, Inc. | Latour Wouter | Director | Aug 12, 2020 | Option Exercise | $0.30 | 166,667 | 50,000 | 333,334 | Aug 12, 2020, 04:32 PM | |
| VXRT | Vaxart, Inc. | Armistice Capital Master Fund Ltd. | Director | Jun 26, 2020 | Sale | $5.57 | 34,893,334 | 194,192,806 | 23,666,667 | Jun 30, 2020, 05:54 PM | |
| VXRT | Vaxart, Inc. | Boyd Steven | Director | Jun 29, 2020 | Option Exercise | $6.11 | 13,476,295 | 82,304,850 | 9,530,909 | Jun 30, 2020, 05:54 PM | |
| VXRT | Vaxart, Inc. | Boyd Steven | Director | Jun 01, 2020 | Sale | $2.74 | 200,000 | 548,000 | 8,200,000 | Jun 03, 2020, 05:45 PM | |
| VXRT | Vaxart, Inc. | Boyd Steven | Director | Jun 02, 2020 | Sale | $2.75 | 800,000 | 2,200,000 | 7,400,000 | Jun 03, 2020, 05:45 PM | |
| VXRT | Vaxart, Inc. | Armistice Capital Master Fund Ltd. | Director | Jun 03, 2020 | Sale | $2.77 | 400,000 | 1,108,000 | 7,000,000 | Jun 03, 2020, 05:45 PM | |
| VXRT | Vaxart, Inc. | Armistice Capital Master Fund Ltd. | 10% Owner | May 27, 2020 | Sale | $2.61 | 200,000 | 522,000 | 8,400,000 | May 29, 2020, 05:22 PM | |
| VXRT | Vaxart, Inc. | Boyd Steven | Director | May 22, 2020 | Sale | $2.86 | 200,000 | 572,000 | 8,600,000 | May 22, 2020, 05:29 PM | |
| VXRT | Vaxart, Inc. | Boyd Steven | Director | May 20, 2020 | Sale | $3.19 | 1,150,000 | 3,668,500 | 9,200,000 | May 22, 2020, 05:29 PM | |
| VXRT | Vaxart, Inc. | Armistice Capital Master Fund Ltd. | 10% Owner | May 21, 2020 | Sale | $2.97 | 400,000 | 1,188,000 | 8,800,000 | May 22, 2020, 05:29 PM | |
| VXRT | Vaxart, Inc. | Boyd Steven | Director | May 14, 2020 | Sale | $3.02 | 834,669 | 2,520,700 | 11,458,639 | May 18, 2020, 05:25 PM | |
| VXRT | Vaxart, Inc. | Boyd Steven | Director | May 15, 2020 | Sale | $2.82 | 458,639 | 1,293,362 | 11,000,000 | May 18, 2020, 05:25 PM | |
| VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | May 18, 2020 | Sale | $2.86 | 650,000 | 1,859,000 | 10,350,000 | May 18, 2020, 05:25 PM | |
| VXRT | Vaxart, Inc. | Armistice Capital Master Fund Ltd. | 10% Owner | May 13, 2020 | Sale | $2.97 | 525,616 | 1,561,080 | 12,293,308 | May 13, 2020, 05:37 PM | |
| VXRT | Vaxart, Inc. | Armistice Capital Master Fund Ltd. | 10% Owner | May 11, 2020 | Sale | $2.79 | 1,300,000 | 3,627,000 | 14,400,000 | May 13, 2020, 05:37 PM | |
| VXRT | Vaxart, Inc. | Boyd Steven | Director | May 12, 2020 | Sale | $3.02 | 1,581,076 | 4,774,849 | 12,818,924 | May 13, 2020, 05:37 PM | |
| VXRT | Vaxart, Inc. | Armistice Capital Master Fund Ltd. | 10% Owner | May 06, 2020 | Sale | $2.58 | 50,000 | 129,000 | 15,900,000 | May 08, 2020, 05:48 PM | |
| VXRT | Vaxart, Inc. | Boyd Steven | Director | May 07, 2020 | Sale | $2.51 | 100,000 | 251,000 | 15,800,000 | May 08, 2020, 05:48 PM | |
| VXRT | Vaxart, Inc. | Boyd Steven | Director | May 08, 2020 | Sale | $2.52 | 100,000 | 252,000 | 15,700,000 | May 08, 2020, 05:48 PM | |
| VXRT | Vaxart, Inc. | Boyd Steven | Director | May 01, 2020 | Sale | $2.71 | 1,000,000 | 2,710,000 | 17,600,000 | May 05, 2020, 05:20 PM | |
| VXRT | Vaxart, Inc. | Armistice Capital Master Fund Ltd. | 10% Owner | May 04, 2020 | Sale | $2.65 | 957,469 | 2,537,293 | 16,642,531 | May 05, 2020, 05:20 PM | |
| VXRT | Vaxart, Inc. | Boyd Steven | Director | May 05, 2020 | Sale | $2.66 | 692,531 | 1,842,133 | 15,950,000 | May 05, 2020, 05:20 PM | |
| VXRT | Vaxart, Inc. | Armistice Capital Master Fund Ltd. | 10% Owner | Apr 29, 2020 | Sale | $3.01 | 873,634 | 2,629,638 | 23,034,296 | Apr 30, 2020, 08:28 PM | |
| VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Apr 30, 2020 | Sale | $2.96 | 4,434,296 | 13,125,516 | 18,600,000 | Apr 30, 2020, 08:28 PM | |
| VXRT | Vaxart, Inc. | Boyd Steven | Director | Apr 28, 2020 | Sale | $3.38 | 1,292,070 | 4,367,197 | 23,907,930 | Apr 30, 2020, 08:28 PM | |
| VXRT | Vaxart, Inc. | Davis Todd C | Director | Apr 28, 2020 | Sale | $3.28 | 60,000 | 196,500 | 120,000 | Apr 30, 2020, 04:10 PM | |
| VXRT | Vaxart, Inc. | Armistice Capital Master Fund Ltd. | 10% Owner | Nov 05, 2019 | Buy | $0.33 | 74,382 | 24,546 | 25,074,382 | Nov 07, 2019, 06:10 PM | |
| VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | Director | Nov 06, 2019 | Buy | $0.34 | 61,869 | 21,035 | 25,136,251 | Nov 07, 2019, 06:10 PM | |
| VXRT | Vaxart, Inc. | Boyd Steven | Director | Nov 07, 2019 | Buy | $0.34 | 63,749 | 21,675 | 25,200,000 | Nov 07, 2019, 06:10 PM | |
| VXRT | Vaxart, Inc. | Richard John P | Director | Oct 11, 2019 | Buy | $0.38 | 20,000 | 7,680 | 20,000 | Oct 15, 2019, 12:19 PM | |
| VXRT | Vaxart, Inc. | Armistice Capital Master Fund Ltd. | 10% Owner | Oct 04, 2019 | Buy | $0.35 | 274,000 | 95,900 | 24,710,000 | Oct 07, 2019, 06:13 PM | |
| VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | 10% Owner | Oct 07, 2019 | Buy | $0.37 | 290,000 | 107,300 | 25,000,000 | Oct 07, 2019, 06:13 PM | |
| VXRT | Vaxart, Inc. | Boyd Steven | 10% Owner | Oct 01, 2019 | Buy | $0.35 | 183,367 | 64,178 | 24,183,367 | Oct 03, 2019, 06:15 PM | |
| VXRT | Vaxart, Inc. | Armistice Capital Master Fund Ltd. | 10% Owner | Oct 02, 2019 | Buy | $0.36 | 23,913 | 8,609 | 24,207,280 | Oct 03, 2019, 06:15 PM | |
| VXRT | Vaxart, Inc. | Boyd Steven | 10% Owner | Oct 03, 2019 | Buy | $0.34 | 228,720 | 77,765 | 24,436,000 | Oct 03, 2019, 06:15 PM | |
| VXRT | Vaxart, Inc. | Boyd Steven | 10% Owner | Sep 26, 2019 | Buy | $0.28 | 4,760,314 | 1,332,888 | 21,426,981 | Sep 30, 2019, 06:55 PM | |
| VXRT | Vaxart, Inc. | Armistice Capital Master Fund Ltd. | 10% Owner | Sep 27, 2019 | Buy | $0.29 | 972,643 | 282,066 | 22,399,624 | Sep 30, 2019, 06:55 PM | |
| VXRT | Vaxart, Inc. | ARMISTICE CAPITAL, LLC | 10% Owner | Sep 30, 2019 | Buy | $0.33 | 1,600,376 | 528,124 | 24,000,000 | Sep 30, 2019, 06:55 PM | |
| VXRT | Vaxart, Inc. | Latour Wouter | President and Chief Executive | Sep 30, 2019 | Buy | $0.30 | 166,667 | 50,000 | 166,667 | Sep 30, 2019, 06:11 PM | |
| VXRT | Vaxart, Inc. | Tucker Sean | Chief Scientific Officer | Apr 11, 2019 | Buy | $1.10 | 27,273 | 30,000 | 52,661 | Apr 12, 2019, 06:04 PM | |
| VXRT | Vaxart, Inc. | Finney Michael J. | Director | Apr 11, 2019 | Buy | $1.10 | 181,818 | 200,000 | 452,572 | Apr 12, 2019, 05:05 PM | |
| VXRT | Vaxart, Inc. | Finney Michael J. | Director | Jun 05, 2018 | Buy | $3.19 | 4,000 | 12,751 | 233,978 | Jun 08, 2018, 05:32 PM | |
| VXRT | Vaxart, Inc. | Finney Michael J. | Director | Jun 04, 2018 | Buy | $4.27 | 1,000 | 4,270 | 229,978 | Jun 08, 2018, 05:32 PM | |
| VXRT | Vaxart, Inc. | Tucker Sean | Chief Scientific Officer | Mar 12, 2018 | Option Exercise | $6.49 | 2,013 | 13,064 | 47,653 | Mar 14, 2018, 09:11 PM | |
| BOTA | Biota Pharmaceuticals, Inc. | COLONNESE MARK P | Chief Financial Officer | Feb 09, 2016 | Buy | $1.41 | 7,000 | 9,847 | 7,000 | Feb 09, 2016, 04:09 PM | |
| BOTA | Biota Pharmaceuticals, Inc. | PATTI JOSEPH M | CEO | Sep 25, 2015 | Buy | $1.87 | 5,000 | 9,338 | 126,128 | Sep 28, 2015, 03:54 PM | |
| BOTA | Biota Pharmaceuticals, Inc. | PLUMB RUSSELL H | Executive Chairman | Sep 16, 2015 | Option Exercise | $2.49 | 12,140 | 30,229 | 203,213 | Sep 18, 2015, 11:54 AM | |
| BOTA | Biota Pharmaceuticals, Inc. | Fox James | Director | Aug 11, 2015 | Option Exercise | $2.49 | 2,500 | 6,225 | 2,500 | Aug 13, 2015, 04:53 PM | |
| BOTA | Biota Pharmaceuticals, Inc. | VANLENT ANNE | Director | Jun 22, 2015 | Buy | $2.20 | 35,000 | 76,891 | 35,000 | Jun 24, 2015, 04:00 PM | |
| BOTA | Biota Pharmaceuticals, Inc. | Fox James | Director | Jun 10, 2015 | Buy | $2.03 | 70,000 | 142,100 | 100,614 | Jun 15, 2015, 04:18 PM | |
| BOTA | Biota Pharmaceuticals, Inc. | Fox James | Director | Jun 09, 2015 | Buy | $1.99 | 70,000 | 139,300 | 100,614 | Jun 11, 2015, 05:13 PM | |
| BOTA | Biota Pharmaceuticals, Inc. | Fox James | Director | May 12, 2015 | Option Exercise | $2.20 | 7,500 | 16,500 | 7,500 | May 14, 2015, 04:13 PM | |
| BOTA | Biota Pharmaceuticals, Inc. | PATTI JOSEPH M | CEO | Mar 27, 2015 | Buy | $2.28 | 20,000 | 45,689 | 121,128 | Mar 31, 2015, 04:00 PM | |
| BOTA | Biota Pharmaceuticals, Inc. | PLUMB RUSSELL H | Vice Chairmen | Oct 01, 2014 | Option Exercise | $2.45 | 40,000 | 98,000 | 40,000 | Oct 02, 2014, 04:43 PM | |
| BOTA | Biota Pharmaceuticals, Inc. | PATTI JOSEPH M | EVP, Corporate Dev & Strategy | Jun 30, 2014 | Buy | $2.86 | 10,000 | 28,600 | 68,241 | Jul 02, 2014, 12:56 PM | |
| BOTA | Biota Pharmaceuticals, Inc. | PATTI JOSEPH M | EVP, Corporate Dev & Strategy | Jun 27, 2014 | Buy | $2.81 | 5,000 | 14,026 | 67,241 | Jun 30, 2014, 03:20 PM | |
| BOTA | Biota Pharmaceuticals, Inc. | PLUMB RUSSELL H | CEO & President | Jun 10, 2014 | Buy | $2.45 | 2,700 | 6,615 | 98,248 | Jun 12, 2014, 04:06 PM | |
| BOTA | Biota Pharmaceuticals, Inc. | PLUMB RUSSELL H | CEO & President | Jun 11, 2014 | Buy | $3.04 | 29,331 | 89,077 | 127,579 | Jun 12, 2014, 04:06 PM | |
| BOTA | Biota Pharmaceuticals, Inc. | PATTI JOSEPH M | EVP, Corporate Dev & Strategy | Jun 10, 2014 | Buy | $2.46 | 8,851 | 21,753 | 56,625 | Jun 12, 2014, 04:05 PM | |
| BOTA | Biota Pharmaceuticals, Inc. | PATTI JOSEPH M | EVP, Corporate Dev & Strategy | Jun 11, 2014 | Buy | $2.88 | 5,616 | 16,172 | 62,241 | Jun 12, 2014, 04:05 PM | |
| BOTA | Biota Pharmaceuticals, Inc. | Fox James | Director | May 15, 2014 | Option Exercise | $2.85 | 7,500 | 21,375 | 7,500 | May 20, 2014, 02:55 PM | |
| NABI | NABI BIOPHARMACEUTICALS | Kessler Paul D. | SVP Clinical, Med. & Reg.; CMO | Apr 05, 2012 | Sale | $1.90 | 5,167 | 9,817 | 105,128 | Apr 09, 2012, 04:21 PM | |
| NABI | NABI BIOPHARMACEUTICALS | Kessler Paul D. | SVP Clinical, Med. & Reg.; CMO | May 16, 2011 | Sale | $5.51 | 12,376 | 68,159 | 115,171 | May 18, 2011, 10:39 AM | |
| NABI | NABI BIOPHARMACEUTICALS | FAHIM RAAFAT E F | President, CEO and CFO | Nov 30, 2010 | Option Exercise | $4.30 | 3,023 | 12,999 | 336,757 | Apr 05, 2011, 05:25 PM | |
| NABI | NABI BIOPHARMACEUTICALS | FAHIM RAAFAT E F | President, CEO and CFO | Apr 05, 2011 | Sale | $5.76 | 13,283 | 76,458 | 373,474 | Apr 05, 2011, 05:25 PM | |
| NABI | NABI BIOPHARMACEUTICALS | FAHIM RAAFAT E F | President, CEO and CFO | May 31, 2010 | Option Exercise | $4.20 | 3,096 | 13,003 | 333,734 | Apr 05, 2011, 05:25 PM | |
| NABI | NABI BIOPHARMACEUTICALS | Kalnik Matthew W. | SVP Strategic Plan. & Bus. Ops | Apr 01, 2011 | Sale | $5.80 | 6,300 | 36,530 | 41,050 | Apr 05, 2011, 05:18 PM | |
| NABI | NABI BIOPHARMACEUTICALS | Kessler Paul D. | SVP Clinical, Med. & Reg.; CMO | Apr 05, 2011 | Sale | $5.76 | 8,596 | 49,479 | 122,671 | Apr 05, 2011, 05:13 PM | |
| NABI | NABI BIOPHARMACEUTICALS | Aryeh Jason | Director | Mar 15, 2011 | Sale | $5.87 | 4,900 | 28,763 | 131,783 | Mar 17, 2011, 03:32 PM | |
| NABI | NABI BIOPHARMACEUTICALS | Aryeh Jason | Director | Mar 14, 2011 | Sale | $5.83 | 3,400 | 19,828 | 137,683 | Mar 16, 2011, 06:31 PM | |
| NABI | NABI BIOPHARMACEUTICALS | Aryeh Jason | Director | Mar 11, 2011 | Sale | $5.76 | 24,700 | 142,171 | 154,883 | Mar 15, 2011, 06:31 PM |
Menu